PURPOSE: To describe the frequency and characteristics of developmental regression in a sample of 50 patients with Phelan McDermid Syndrome (PMS) and investigate the possibility of association between regression, epilepsy, and electroencephalogram (EEG) abnormalities and deletion size. METHODS: The Autism Diagnostic Interview-Revised (ADI-R) was used to evaluate regression in patients with a confirmed diagnosis of PMS. Information on seizure history and EEGs was obtained from medical record review. Deletion size was determined by DNA microarray. RESULTS: A history of regression at any age was present in 43% of all patients. Among those exhibiting regression, 67% had onset after the age of 30 months, affecting primarily motor and self-help skills. In 63% of all patients there was a history of seizures and a history of abnormal EEG was also present in 71%. No significant associations were found between regression and seizures or EEG abnormalities. Deletion size was significantly associated with EEG abnormalities, but not with regression or seizures. CONCLUSION: This study found a high rate of regression in PMS. In contrast to regression in autism, that often occurs earlier in development and affects language and social skills, we found regression in PMS most frequently has an onset in mid-childhood, affecting motor and self-help skills. We also found high rates of seizures and abnormal EEGs in patients with PMS. However, a history of abnormal EEG and seizures was not associated with an increased risk of regression. Larger deletion sizes were found to be significantly associated with a history of abnormal EEG.
PURPOSE: To describe the frequency and characteristics of developmental regression in a sample of 50 patients with Phelan McDermid Syndrome (PMS) and investigate the possibility of association between regression, epilepsy, and electroencephalogram (EEG) abnormalities and deletion size. METHODS: The Autism Diagnostic Interview-Revised (ADI-R) was used to evaluate regression in patients with a confirmed diagnosis of PMS. Information on seizure history and EEGs was obtained from medical record review. Deletion size was determined by DNA microarray. RESULTS: A history of regression at any age was present in 43% of all patients. Among those exhibiting regression, 67% had onset after the age of 30 months, affecting primarily motor and self-help skills. In 63% of all patients there was a history of seizures and a history of abnormal EEG was also present in 71%. No significant associations were found between regression and seizures or EEG abnormalities. Deletion size was significantly associated with EEG abnormalities, but not with regression or seizures. CONCLUSION: This study found a high rate of regression in PMS. In contrast to regression in autism, that often occurs earlier in development and affects language and social skills, we found regression in PMS most frequently has an onset in mid-childhood, affecting motor and self-help skills. We also found high rates of seizures and abnormal EEGs in patients with PMS. However, a history of abnormal EEG and seizures was not associated with an increased risk of regression. Larger deletion sizes were found to be significantly associated with a history of abnormal EEG.
Authors: S U Dhar; D del Gaudio; J R German; S U Peters; Z Ou; P I Bader; J S Berg; M Blazo; C W Brown; B H Graham; T A Grebe; S Lalani; M Irons; S Sparagana; M Williams; J A Phillips; A L Beaudet; P Stankiewicz; A Patel; S W Cheung; T Sahoo Journal: Am J Med Genet A Date: 2010-03 Impact factor: 2.802
Authors: Wendy Froehlich; Sue Cleveland; Andrea Torres; Jennifer Phillips; Brianne Cohen; Tiffany Torigoe; Janet Miller; Angie Fedele; Jack Collins; Karen Smith; Linda Lotspeich; Lisa A Croen; Sally Ozonoff; Clara Lajonchere; Judith K Grether; Joachim Hallmayer Journal: J Autism Dev Disord Date: 2013-09
Authors: H L Wilson; A C C Wong; S R Shaw; W-Y Tse; G A Stapleton; M C Phelan; S Hu; J Marshall; H E McDermid Journal: J Med Genet Date: 2003-08 Impact factor: 6.318
Authors: Daniela M Cochoy; Alexander Kolevzon; Yuji Kajiwara; Michael Schoen; Maria Pascual-Lucas; Stacey Lurie; Joseph D Buxbaum; Tobias M Boeckers; Michael J Schmeisser Journal: Mol Autism Date: 2015-04-29 Impact factor: 7.509
Authors: Mariagiovanna Malara; Anne-Kathrin Lutz; Berra Incearap; Helen Friedericke Bauer; Silvia Cursano; Katrin Volbracht; Joanna Janina Lerner; Rakshita Pandey; Jan Philipp Delling; Valentin Ioannidis; Andrea Pérez Arévalo; Jaime Eugenin von Bernhardi; Michael Schön; Jürgen Bockmann; Leda Dimou; Tobias M Boeckers Journal: Cell Mol Life Sci Date: 2022-06-20 Impact factor: 9.207
Authors: Sergio Serrada-Tejeda; Rosa M Martínez-Piédrola; Nuria Máximo-Bocanegra; Patricia Sánchez-Herrera-Baeza; Marta Pérez-de-Heredia-Torres Journal: Front Neurosci Date: 2022-07-04 Impact factor: 5.152
Authors: Anastasia K Neklyudova; Galina V Portnova; Anna B Rebreikina; Victoria Yu Voinova; Svetlana G Vorsanova; Ivan Y Iourov; Olga V Sysoeva Journal: Int J Mol Sci Date: 2021-02-14 Impact factor: 5.923
Authors: Paige M Siper; Mikaela A Rowe; Sylvia B Guillory; Audrey A Rouhandeh; Julia L George-Jones; Teresa Tavassoli; Stacey Lurie; Jessica Zweifach; Jordana Weissman; Jennifer Foss-Feig; Danielle Halpern; M Pilar Trelles; Maureen S Mulhern; Chloe Brittenham; James Gordon; Vance Zemon; Joseph D Buxbaum; Alexander Kolevzon Journal: J Am Acad Child Adolesc Psychiatry Date: 2021-07-22 Impact factor: 8.829
Authors: Silvia De Rubeis; Paige M Siper; Allison Durkin; Jordana Weissman; François Muratet; Danielle Halpern; Maria Del Pilar Trelles; Yitzchak Frank; Reymundo Lozano; A Ting Wang; J Lloyd Holder; Catalina Betancur; Joseph D Buxbaum; Alexander Kolevzon Journal: Mol Autism Date: 2018-04-27 Impact factor: 7.509